Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome.
about
Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategiesTherapy-related myeloid neoplasms - what have we learned so far?Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous diseaseTherapy-related myeloid neoplasms: pathobiology and clinical characteristicsThe clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemiasCore-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation.Therapy of core binding factor acute myeloid leukemia: incremental improvements toward better long-term results.Older patients with acute myeloid leukemia.A focused review of hematopoietic neoplasms occurring in the therapy-related setting.Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors.Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.OGG1 is a novel prognostic indicator in acute myeloid leukaemia.Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning.Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia.Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.Acute myeloid leukemia
P2860
Q26770394-5E0EEED3-7924-4334-8929-E572EC777A07Q28071318-31D15D0C-10B6-45CC-8A8C-500A4B27F8D5Q28282623-16B5A21C-0C26-4930-AEE5-F6726DE90DE1Q28386366-764A240D-4DBB-481E-AEFD-D224B4CA9FF5Q33407572-B37B35D1-6F5E-4232-AF22-1957DAE550FDQ33421005-A6D0D306-E2B6-4E58-9BC7-0852446A9010Q34169601-1295E5B0-EF60-4C1C-B4D3-36A853CA61E9Q34663691-971A83B4-91F8-443C-8662-F46DEA7B5137Q34851156-8938CDAB-4A08-4014-9C13-5EE1A10B100EQ34976428-72D9E207-60E7-42B9-B084-F741B29C05F6Q37372832-E7C98E88-B1F3-4B59-B421-32EA6B242AB3Q37810969-100728E8-061D-4F55-BDF7-B5901972A9E7Q38239675-F2E5A9A6-7761-4513-ABCB-1D50EB070FBCQ38263126-CE9A2B7D-6AE4-44B8-8F0D-3392377B06DCQ38904250-5E92955C-2F5C-4A88-8029-79160B9AC39EQ41973082-D968FEDD-84D0-46E0-BBFB-696E06917F33Q43214271-2AF8B808-DDAE-4C95-A089-C4E593F4DC3CQ49419358-E218DBE6-D29B-48E1-8C2E-776B829B7FE8Q52817300-96231561-C6B8-4EDF-80D6-9325AADC42E6Q53100468-534061DA-22F1-460D-88DF-DCA1F8952F6EQ58481761-79921069-B63F-4BFB-92A0-8EF1E156B8A5
P2860
Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Therapy-related acute myeloid leukemia with t
@nl
Therapy-related acute myeloid ...... not have a favorable outcome.
@en
type
label
Therapy-related acute myeloid leukemia with t
@nl
Therapy-related acute myeloid ...... not have a favorable outcome.
@en
prefLabel
Therapy-related acute myeloid leukemia with t
@nl
Therapy-related acute myeloid ...... not have a favorable outcome.
@en
P2093
P2860
P356
P1476
Therapy-related acute myeloid ...... not have a favorable outcome.
@en
P2093
L Jeffrey Medeiros
Lynne V Abruzzo
Rajyalakshmi Luthra
Steven A Gustafson
P2860
P304
P356
10.1309/AJCP5ETHDXO6NCGZ
P407
P577
2009-05-01T00:00:00Z